SQI Diagnostics Valuation

SQIDFDelisted Stock  USD 0.01  0.00  0.00%   
SQI Diagnostics seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of SQI Diagnostics from examining the company fundamentals such as shares outstanding of 406.25 M, and Return On Equity of -12.54 as well as evaluating its technical indicators and probability of bankruptcy.
Overvalued
Today
0.01
Please note that SQI Diagnostics' price fluctuation is somewhat reliable at this time. Calculation of the real value of SQI Diagnostics is based on 3 months time horizon. Increasing SQI Diagnostics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the SQI pink sheet is determined by what a typical buyer is willing to pay for full or partial control of SQI Diagnostics. Since SQI Diagnostics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of SQI Pink Sheet. However, SQI Diagnostics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.0149 Real  0.0127 Hype  0.0149 Naive  0.0149
The real value of SQI Pink Sheet, also known as its intrinsic value, is the underlying worth of SQI Diagnostics Company, which is reflected in its stock price. It is based on SQI Diagnostics' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of SQI Diagnostics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
0.01
Real Value
0.02
Upside
Estimating the potential upside or downside of SQI Diagnostics helps investors to forecast how SQI pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of SQI Diagnostics more accurately as focusing exclusively on SQI Diagnostics' fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.010.010.01
Details
Hype
Prediction
LowEstimatedHigh
0.010.010.02
Details
Naive
Forecast
LowNext ValueHigh
0.010.010.01
Details

SQI Diagnostics Total Value Analysis

SQI Diagnostics is at this time forecasted to have takeover price of 34.24 M with market capitalization of 34.43 M, debt of 6.3 M, and cash on hands of 3.96 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the SQI Diagnostics fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
34.24 M
34.43 M
6.3 M
3.96 M

SQI Diagnostics Investor Information

About 51.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.02. SQI Diagnostics had not issued any dividends in recent years. Based on the key indicators related to SQI Diagnostics' liquidity, profitability, solvency, and operating efficiency, SQI Diagnostics is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.

SQI Diagnostics Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. SQI Diagnostics has an asset utilization ratio of 86.98 percent. This implies that the Company is making $0.87 for each dollar of assets. An increasing asset utilization means that SQI Diagnostics is more efficient with each dollar of assets it utilizes for everyday operations.

SQI Diagnostics Ownership Allocation

SQI Diagnostics shows a total of 406.25 Million outstanding shares. SQI Diagnostics maintains noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.

SQI Diagnostics Profitability Analysis

The company reported the revenue of 8.1 M. Net Loss for the year was (18.52 M) with profit before overhead, payroll, taxes, and interest of 3.1 M.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates SQI Diagnostics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in SQI Diagnostics and how it compares across the competition.

About SQI Diagnostics Valuation

The pink sheet valuation mechanism determines SQI Diagnostics' current worth on a weekly basis. Our valuation model uses a comparative analysis of SQI Diagnostics. We calculate exposure to SQI Diagnostics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of SQI Diagnostics's related companies.
SQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. SQI Diagnostics Inc. was founded in 1999 and is headquartered in Toronto, Canada. Sqi Diagnostics is traded on OTC Exchange in the United States.

8 Steps to conduct SQI Diagnostics' Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates SQI Diagnostics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct SQI Diagnostics' valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain SQI Diagnostics' financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine SQI Diagnostics' revenue streams: Identify SQI Diagnostics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research SQI Diagnostics' industry and market trends, including the size of the market, growth rate, and competition.
  • Establish SQI Diagnostics' growth potential: Evaluate SQI Diagnostics' management, business model, and growth potential.
  • Determine SQI Diagnostics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate SQI Diagnostics' estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

SQI Diagnostics Growth Indicators

Investing in growth stocks can be very risky. If the company such as SQI Diagnostics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding393.6 M
Retained Earnings-132.5 M
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Consideration for investing in SQI Pink Sheet

If you are still planning to invest in SQI Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SQI Diagnostics' history and understand the potential risks before investing.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Bonds Directory
Find actively traded corporate debentures issued by US companies
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities